ENDPOINTS

Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff 

Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Sutro Biopharma and Idorsia: Vertanical’s non-opioid painkiller succeeds in Phase 3: The German biotech claimed a late-stage win in chronic back pain for its ...

Mar 17, 2025 - 16:00
 0
Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff 
Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Sutro Biopharma and Idorsia: Vertanical’s non-opioid painkiller succeeds in Phase 3: The German biotech claimed a late-stage win in chronic back pain for its ...
Read More

Tags:

Previous Article

Ford Mustang Mach-E & F-150 Lightning Drivers Get Tesla Superchargers Added on A...

Next Article

Quantum Speedup Found for Huge Class of Hard Problems

Related Posts

Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M

Altimmune to put its incretin into addiction trials; Ta...

Mar 14, 2025  0

Eli Lilly-backed Maxion Therapeutics raises $72M Series A to advance its antibody approach

Eli Lilly-backed Maxion Therapeutics raises $72M Series...

Mar 17, 2025  0

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

Repare to lay off 75% of staff; Castle Creek inks $75M ...

Feb 25, 2025  0